Viacord, LLC
Records under this name other than patents Viacord, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,613,906 | Treatment of ischemia using stem cells Lapsed on the fee record Ended Dec 24, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 24, 2025 | From the USPTO record |
| US 7,452,529 | Treatment of muscular dystrophy with cord blood cells Term ended Term ended Jul 23, 2022 · From the USPTO record | Term ended | Term ended Jul 23, 2022 | From the USPTO record |
| US 7,811,557 | Methods for improving central nervous system functioning Term ended Term ended May 11, 2022 · From the USPTO record | Term ended | Term ended May 11, 2022 | From the USPTO record |
| US 7,560,280 | Human cord blood derived unrestricted somatic stem cells (USSC) Lapsed on the fee record Ended Jul 14, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jul 14, 2021 | From the USPTO record |
| US 7,556,801 | Human cord blood derived unrestricted somatic stem cells (USSC) Lapsed on the fee record Ended Jul 7, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jul 7, 2021 | From the USPTO record |
| US 9,072,740 | Methods of Improving Central Nervous System Functioning Term ended Ended no later than Jun 6, 2021 · Low confidence | Term ended | Ended no later than Jun 6, 2021 | Low confidence |
| US 8,337,833 | Methods of improving central nervous system functioning Formerly held Term ended Term ended Oct 27, 2020 · From the USPTO record | Term ended | Term ended Oct 27, 2020 | From the USPTO record |
| US 6,429,012 | Cell population containing non-fetal hemangioblasts and method for producing same Term ended Term ended Oct 6, 2017 · From the USPTO record | Term ended | Term ended Oct 6, 2017 | From the USPTO record |
| US 6,338,942 | Selective expansion of target cell populations Term ended Ended no later than May 19, 2015 · From the USPTO record | Term ended | Ended no later than May 19, 2015 | From the USPTO record |
| US 5,674,750 | Continuous selective clonogenic expansion of relatively undifferentiated cells Term ended Term ended no later than Oct 7, 2017 · Low confidence | Term ended | Term ended no later than Oct 7, 2017 | Low confidence |